Tofacitinib citrate

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Tofacitinib citrate
CAS No.:540737-29-9
Standard:ChP, USP, In-house Standards
Price(USD):Negotiable
Company:Senova Technology Company Limited

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: GuangDong

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Tofacitinib citrate is a king of drugs developed by the US pharmaceutical company Pfizer for treating rheumatoid arthritis, trade name Xeljanz, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients. This product is a Janus kinase inhibitor, administered twice daily.

Send your message to this supplier
  • From:
  • To:
    Senova Technology Company Limited
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service